CIK 0001858848
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tenaya Therapeutics, Inc.
Sign in to watch- Ticker
- TNYA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813789973
- Phone
- +1 415-865-2066
- Business address
- 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-17 | Ali Faraz Chief Executive Officer | Sale | −5,837 | $0.71 | $4K | 434,177 |
| 2026-08-17 | Ali Faraz Chief Executive Officer | Sale | −3,969 | $0.71 | $3K | 430,208 |
| 2026-08-17 | Ali Faraz Chief Executive Officer | Sale | −5,020 | $0.71 | $4K | 425,188 |
| 2026-08-17 | Ali Faraz Chief Executive Officer | Sale | −7,406 | $0.71 | $5K | 417,782 |
| 2026-08-17 | Tingley Whittemore Chief Medical Officer | Sale | −1,637 | $0.71 | $1K | 219,860 |
| 2026-08-17 | Tingley Whittemore Chief Medical Officer | Sale | −1,637 | $0.71 | $1K | 218,223 |
| 2026-08-17 | Tingley Whittemore Chief Medical Officer | Sale | −1,871 | $0.71 | $1K | 216,352 |
| 2026-08-17 | Tingley Whittemore Chief Medical Officer | Sale | −2,279 | $0.71 | $2K | 214,073 |
| 2026-05-18 | Ali Faraz Chief Executive Officer | Sale | −3,390 | $0.79 | $3K | 440,014 |
| 2026-05-18 | Tingley Whittemore Chief Medical Officer | Sale | −3,121 | $0.79 | $2K | 215,497 |
| 2026-05-18 | Higa Tomohiro SVP, Finance | Sale | −1,485 | $0.79 | $1K | 118,267 |
| 2026-02-25 | COLUMN GROUP III GP, LP 10% owner | Sale | −1,649,281 | $0.56 | $928K | 0 |
| 2026-02-25 | COLUMN GROUP III GP, LP 10% owner | Sale | −1,862,545 | $0.56 | $1.0M | 0 |
| 2026-02-24 | COLUMN GROUP III GP, LP 10% owner | Sale | −309,228 | $0.62 | $190K | 1,649,281 |
| 2026-02-24 | COLUMN GROUP III GP, LP 10% owner | Sale | −349,212 | $0.62 | $215K | 1,862,545 |
| 2026-02-23 | COLUMN GROUP III GP, LP 10% owner | Sale | −143,709 | $0.60 | $86K | 1,958,509 |
| 2026-02-23 | COLUMN GROUP III GP, LP 10% owner | Sale | −162,291 | $0.60 | $97K | 2,211,757 |
| 2026-02-20 | COLUMN GROUP III GP, LP 10% owner | Sale | −245,965 | $0.61 | $151K | 2,102,218 |
| 2026-02-20 | COLUMN GROUP III GP, LP 10% owner | Sale | −277,769 | $0.61 | $171K | 2,374,048 |
| 2026-02-17 | Higa Tomohiro SVP, Finance | Sale | −611 | $0.64 | $393 | 122,610 |
Page 1 of 4 · 75 trades